EPFL spinout MindMaze has raised $105m from investors including AlbaCore Capital, which had supplied $125m in capital only four months ago.

MindMaze, a Switzerland-based digital neurotherapeutics platform spun out of EPFL, received $105m in a funding round on Thursday led by private equity firm Concord Health Partners.

The round also featured AlbaCore Capital, Hambro Perks and several unnamed family offices. Although an updated valuation was not disclosed, MindMaze is worth at least $1.5bn.

Founded in 2012, MindMaze has built a digital health platform using technologies such as artificial intelligence, mixed…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).